{
  "id": 3567074,
  "title": "FDA approves Revolution Medicines' first targeted drug for advanced pancreatic cancer",
  "url": "https://urgent.news/2026/08/26/fda-approves-revolution-medicines-first-targeted-drug-for-advanced",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-26T18:20:38.000Z",
  "source": {
    "name": "Quartz",
    "slug": "quartz",
    "url": "https://qz.com/revolution-medicines-fda-approval-daraxonrasib-pancreatic-cancer-082626"
  },
  "original_language": "en",
  "account": null,
  "summary": "The drug, Rasonque, nearly doubled median overall survival compared with standard chemotherapy in a 500-patient trial",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Semafor",
        "title": "FDA approves breakthrough drug for pancreatic cancer treatment",
        "url": "https://urgent.news/2026/08/26/fda-approves-breakthrough-drug-for-pancreatic-cancer-treatment",
        "published": "2026-08-26T22:32:07.000Z"
      },
      {
        "outlet": "CBS News",
        "title": "FDA approves new pancreatic cancer drug that could extend patients' lives",
        "url": "https://urgent.news/2026/08/26/fda-approves-new-pancreatic-cancer-drug-that-could-extend-patients",
        "published": "2026-08-26T23:02:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}